KIMBERLEY BEDARD: Open Payments
NPI 1265881759 · FARMINGTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$300 in 3 payments from 3 companies in 2025. Trend: 2023 $465 · 2024 $222 · 2025 $300
Food & beverage: $300
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Neurocrine BioSciences, Inc. | 1 | $123 |
| McKesson Medical-Surgical Minnesota Supply, Inc | 1 | $52 |
Products named: REXULTI, INGREZZA.
Industry payments across CT — which companies pay providers there.
